Investor Info
Our Presentation
Cap Table
MustGrow is publicly traded (CSE:MGRO) (OTCQX:MGROF) (FRA:0C0) agricultural biotech company focused on providing natural science-based biological solutions for high value crops, including fruit & vegetable cultivation.
| CAPITAL STRUCTURE | |
|---|---|
| Basic Shares Outstanding | 43,462,566 |
| Options | 3,725,000 |
| Warrants | 3,388,694 |
| Fully-Diluted Shares Outstanding | 50,576,260 |
| Insider Ownership (~18%) | 7,971,647 |
| CSE Average Volume (3 month) | 65,740 |
| Previous Capital Spent (C$MM) | $15.0 |
| Cash Position (C$MM) | $3.1 |
| Debt (C$MM) | $1.0 |
Natural Technology Platform with the Efficacy of Synthetic Chemicals
- 100% owned patented mustard-derived technology; harnessing the natural defense mechanism of the mustard seed.
- MustGrow’s natural biological solutions to replace synthetic chemicals used in high value crops such as fruit & vegetables and other industries.
- Regulatory agencies are restricting or banning existing synthetic chemistries leaving limited alternatives.
- Consumers are demanding healthy, natural and organic products.
- Producers want to protect their crops with bilogicals but only if they work -- may bilogicals have as today not met performance expectations.
- Agchem companies are actively investing in more sustainable natural technologies to replace or compliment synthetic chemicals.
- Sustainable farming practices are critical to feed a growing global
population on a finite amount of land.
Technology Platform with Application in Many Markets
-
Preplant Soil Biofumigant for multiple crops such as fruit, vegetable, turf and ornamental crops.
-
Bioherbicide with unique mode of action for organic acres, home & garden and jurisdictions where glyphosate is out of favor or banned.
-
Postharvest Biopesticide for storage and food preservation (F&V, bulk grain, shipping containers and food borne pathogens).
Technology Pipeline
FINANCIAL STATEMENTS
2021 Financials
2020 Financials
Q1-2021
Q2-2021
Q1-2020
News Releases
MustGrow Biologics Arranges $2 Million Equity Private Placement
MustGrow Biologics Arranges $2 Million Equity Private Placement SASKATOON, Saskatchewan, Canada, September 13, 2021 – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) is pleased to announce a non-brokered private placement (the “Private...
MustGrow Biologics and Sumitomo Corporation Announce Exclusive Agreement
MustGrow Biologics and Sumitomo Corporation Announce Exclusive Agreement Exclusive agreement with Sumitomo Corporation to evaluate MustGrow’s technology to determine commercial potential. Sumitomo Corporation has option to acquire exclusive rights to MustGrow’s...
MustGrow Biologics Announces Positive Carnation Trials with Gowan
MustGrow Biologics Announces Positive Carnation Trials with Gowan Work completed under non-exclusive agreement with Gowan Group’s biological division Ecoflora Agro in Colombia. MustGrow and Gowan reported control of Fusarium disease in carnation flower soil utilizing...